IDEXX Surpasses Earnings Expectations, Justifying Premium Valuation
1. IDEXX reported Q2 2025 earnings of $3.50, exceeding expectations. 2. Sales reached $1.11 billion, up 11%, driven by Companion Animal Group growth. 3. Fiscal 2025 guidance raised for earnings and revenues, indicating optimism. 4. Gross margin improved to 62.6% with strong VetLab consumables sales. 5. William Blair analysts maintain Outperform rating on IDXX stocks.